CD34 and myelodysplastic syndrome: In patient #3 (a 32-year old female, relapse sample, AML transformed from MDS), 47% of blast cells within the CD34- fraction and only 14% of CD34+ cells expressed NPM1mut (allelic frequency of 23.7% vs 7%).